Elevated Procollagen Type I Carboxyterminal Propeptide Production in Cultured Scleroderma Fibroblasts
- 1 January 1995
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 190 (2) , 104-108
- https://doi.org/10.1159/000246656
Abstract
Background: We recently reported that the serum concentration of procollagen type I carboxyterminal propeptide (P1CP) in patients with systemic sclereosis (SSc) was elevated. In the present study, we investigated collagen metabolism in in vitro cultured scleroderma fibroblasts by measuring P1CP levels in the culture medium. Methods and Results: Spontaneous PICP production was 4.2 times higher in fibroblast cultures from patients with SSc (n = 11) than in those from healthy controls (n = 10). P1CP production in fibroblasts derived from diffuse cutaneous SSc patients was significantly greater than that from limited cutaneous SSc patients. The serum P1CP level in SSc patients was correlated with the P1CP production of cultured fibroblasts (r = 0.815, p Conclusion: These findings suggest that P1CP production in SSc fibroblasts is relevant to in vivo collagen synthesis in SSc patients.Keywords
This publication has 0 references indexed in Scilit: